Efficacy of INK128, an mTORC1/mTORC2 kinase inhibitor, in breast cancer models driven by HER2-PI3K-AKT-mTOR pathway.
Pradip De
No relevant relationships to disclose
Yuliang Sun
No relevant relationships to disclose
Hui Wu
No relevant relationships to disclose
Christian Rommel
No relevant relationships to disclose
Yi Liu
No relevant relationships to disclose
Nandini Dey
No relevant relationships to disclose
Brian Leyland-Jones
No relevant relationships to disclose